1
Clinical Trials associated with Anti-GPC3 therapy(Band Therapeutics, LLC)A phase I study of combination immunotherapy with HSP70 derived peptide, GPC3 derived peptide, IMP321 and Hiltonol for patients with advanced or metastatic solid cancer - A phase I study of combination immunotherapy with HSP70 derived peptide, GPC3 derived peptide, IMP321 and Hiltonol for patients with advanced or metastatic solid cancer
Start Date12 Jan 2016 |
Sponsor / Collaborator- |
100 Clinical Results associated with Anti-GPC3 therapy(Band Therapeutics, LLC)
100 Translational Medicine associated with Anti-GPC3 therapy(Band Therapeutics, LLC)
100 Patents (Medical) associated with Anti-GPC3 therapy(Band Therapeutics, LLC)
100 Deals associated with Anti-GPC3 therapy(Band Therapeutics, LLC)